1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with fluorouracil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Ding, XQ; Ma, CM; Wang, JY; Zhao, S; Zheng, HC | 1 |
2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and fluorouracil
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibitory effects and molecular mechanisms of pentagalloyl glucose in combination with 5-FU on aggressive phenotypes of HepG2 cells.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Fluorouracil; Hep G2 Cells; Humans; Hydrolyzable Tannins; Membrane Potential, Mitochondrial; Neoplasm Invasiveness; Phenotype | 2021 |